drugset / Trial / NCT01125124
Safety and Effectiveness Study for Pleurodesis With Silver Nitrate in Malignant Pleural Effusion
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary purpose of this study is to determinate the degree of chest pain on patients with malignant pleural effusion submitted to pleurodesis with silver nitrate in three different dosages and concentrations ( 30ml 0.5% ; 30ml 0.3% ; 60ml 0.3%). Our secondary purpose is to evaluate the efficacy and occurence of adverse effects in the usage of silver nitrate for pleurodesis in the aforementioned dosages/concentrations.
Timeline
- Start
- 2009-08
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Silver Nitrate | Other / unclassified | 0.3 % | Other |
| Subject | Silver Nitrate | Other / unclassified | 0.5 % | Other |
| Subject | Silver Nitrate | Other / unclassified | 30 ml | Other |
| Subject | Silver Nitrate | Other / unclassified | 60 ml | Other |